StageZero Life Sciences Announces Q4 2020 and Year End Financial Results and Operational Update
Q4 Revenue of $2.82 Million TORONTO, ON / ACCESSWIRE / April 1, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero"...
News
Inspyr Therapeutics Reports Financial Results and Business Update For Full Year 2020
Implements new corporate strategy to focus on precision therapeutics for the treatment of cancer Strengthens pipeline by acquiring a proprietary...
DiagnostiX Aims to go Public Through a SPAC by the End of 2021
MANHATTAN, NY / ACCESSWIRE / April 1, 2021 / With DiagnostiX's increasing growth and recent announcement of a €20M Series...
Ciitizen Partners with Three Leading Advocacy Groups to Improve Patient Outcomes for SCN8A-related Disorders
The Cute Syndrome Foundation, Shay Emma Hammer Research Foundation, and Wishes for Elliott have come together to create longitudinal SCN8A...
US State Turns on COVID-19 Vaccine Appointment Scheduling Hotline in Less Than a Day with Bright Pattern
COVID-19 vaccine appointment hotline deployed in record time – 23 hours – by Atento and Bright Pattern with an agreement...
StageZero Life Sciences Announces Signed Letter of Intent for the Acquisition of Health Clinics Limited
Initiates AVRT program for the early detection of diseases, with a focus on cancer incorporating its Aristotle multi-cancer panel TORONTO,...
Kadmon Doses First Patient in Open-Label Phase 2 Clinical Trial of Belumosudil in Systemic Sclerosis
NEW YORK, NY / ACCESSWIRE / April 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced that the first patient has been...
Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan
ENGLEWOOD, CO / ACCESSWIRE / April 1, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate...
Innovative MedTech Acquires Adult Recreation and Health Facility Corporation SarahCare as Initial Subsidiary to Address Supportive Adult Care
Significant investment made into Innovative MedTech, which the Company used to close its first major acquisition BLUE ISLAND, IL /...
Aytu BioPharma Divests U.S. Rights to Natesto(R) to Acerus Pharma
Strategic Transaction Provides $7.5M in Non-Dilutive Capital and Enables Pediatric and ADHD Product Focus Following the Recently Closed Merger with...
Meridian Bioscience Announces FDA Submission for New Curian® Campy Assay
CINCINNATI, April 01, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a leading global provider of diagnostic testing solutions...
Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics
Shareholders of Infant Bacterial Therapeutics AB (publ) are summoned to the Annual General Meeting on Tuesday, May 4, 2021. In light of the...
Autolus Therapeutics Receives PRIME designation for AUTO1 for the treatment of adult ALL
LONDON, April 01, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell...
10x Genomics Puts Single Cell Analysis Within Reach of All With Low Throughput Gene Expression Kit
Along with recent release of CellPlex, product increases access through affordabilityPLEASANTON, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- 10x Genomics,...
Poster on Celsion Corporation’s Phase I/II OVATION 2 Study Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women’s Cancer
Company reports further strengthening of R0 resection results in patients treated with GEN-1 LAWRENCEVILLE, N.J., April 01, 2021 (GLOBE NEWSWIRE)...
BioCorRx Provides 2020 Year-End Business Update
ANAHEIM, CA, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced...
Vincerx Pharma Announces Formation of Scientific Advisory Board to Advance its Clinical Pipeline
PALO ALTO, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the...
eGenesis Expands Research Collaboration with Leading Academic Medical Center
Collaboration will now include in vivo testing of lead kidney xenotransplant program in addition to pancreatic islet xenotransplant program CAMBRIDGE,...
Onconova Therapeutics Announces Enrollment in Second Cohort of Phase 1 Study with ON 123300 in China
Corporate Partner HanX Biopharmaceuticals enrolled third patient in 80 mg groupNEWTOWN, Pa., April 01, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics,...
Nabriva Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
DUBLIN, Ireland and KING OF PRUSSIA, Pa., April 01, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical...